KIF2A and lung carcinoma: KIF2A was also shown to influence lung cancer response to chemotherapy, as knockdown sensitized A549, H1975, and H1299 cells to cisplatin and paclitaxel [166,169], while overexpression conferred resistance to cisplatin [167].